Curaleaf HoldingsCURLF +0.69%67 EV-to-OCF is 27.65 as of Jul. 08, 2026, which is 68% above its 10-year median of 16.48. GuruFocus rates CURLF with a GF Score™ of 67/100 and a GF Value™ of $7.98 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Curaleaf Holdings ranks worse than 77.78% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Curaleaf Holdings's Enterprise Value is $3,325 Mil.
Curaleaf Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $120 Mil. Therefore, Curaleaf Holdings's EV-to-OCF for today is 27.65.
The historical rank and industry rank for Curaleaf Holdings's EV-to-OCF or its related term are showing as below:
CURLF'
s EV-to-OCF Range Over the Past 10 Years
Min: -1709.23 Med: 16.48 Max: 2095.18
Current: 27.65
During the past 12 years, the highest EV-to-OCF of Curaleaf Holdings was 2095.18. The lowest was -1709.23. And the median was 16.48.
CURLF's EV-to-OCF is ranked worse than 77.78% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 10.635
vs CURLF: 27.65
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Curaleaf Holdings's PE Ratio (TTM) for today is calculated as:
Curaleaf Holdings's share price for today is $9.465.
Curaleaf Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.607.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Curaleaf Holdings EV-to-OCF Related Terms
Curaleaf Holdings EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Curaleaf Holdings's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Curaleaf Holdings EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Curaleaf Holdings's EV-to-OCF falls into.
Curaleaf Holdings's current Enterprise Value is $3,325 Mil.
Curaleaf Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $120 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Curaleaf Holdings (CURLF) has a EV-to-OCF of 27.65 as of Jul. 08, 2026. This is 68% above median its historical median of 16.48. According to the industry distribution chart, Curaleaf Holdings ranks #784 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 77.8%.
Is Curaleaf Holdings' EV-to-OCF too high?
Curaleaf Holdings' current EV-to-OCF of 27.65 is 68% above median its 10-year median of 16.48. The Drug Manufacturers industry median EV-to-OCF is 10.64. Curaleaf Holdings' value of 27.65 is 160% above this industry median. Based on the distribution chart, Curaleaf Holdings ranks #784 out of 1008 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Curaleaf Holdings has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Curaleaf Holdings' EV-to-OCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Curaleaf Holdings ranks #784 out of 1008 companies for EV-to-OCF. This places Curaleaf Holdings in the lower half of its industry. The industry median EV-to-OCF is 10.64. Curaleaf Holdings' value of 27.65 is 160% above this benchmark. While the company's 10-year median is 16.48 vs. the industry median of 10.64, Curaleaf Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.64, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Curaleaf Holdings's current EV-to-OCF of 27.65 is 160% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Curaleaf Holdings's current EV-to-OCF is 27.65, which is 68% above median its own 10-year median of 16.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curaleaf Holdings stock overvalued right now?
Based on GuruFocus' analysis, Curaleaf Holdings (CURLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $7.98, compared to a current price of $9.47 — trading 18.6% above its estimated fair value. The current EV-to-OCF is 27.65, which is 68% above median its 10-year median of 16.48 and 160% above the Drug Manufacturers industry median of 10.64. Curaleaf Holdings' overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Curaleaf Holdings (CURLF), the current EV-to-OCF is 27.65 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Curaleaf Holdings (CURLF) Overvalued in 2026?
Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued.
The current stock price of $9.47 is trading 18.6% above its estimated GF Value™ of $7.98.
GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.
Key valuation signals for CURLF:
EV-to-OCF: 27.65 (68% above median its 10-year median of 16.48)
GF Value™: $7.98 vs. price of $9.47 (18.6% above fair value)
Industry Position: 160% above the Drug Manufacturers median (#784 of 1008)
No single metric tells the full story. See the CURLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
67GF Score
Get the complete analysis for CURLF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CURLF has been successfully added to your 
